Nordic Bioscience Investor

Nordic Bioscience is dedicated to preclinical and clinical drug development, specializing in personalized medicine using unique biomarker.

Invests into

Industry: Omic
Headquarters: Herlev, Hovedstaden, Denmark
Founded Date: 1991-01-01
Employees Number: 51-100
Funding Status: Private Equity
Number Of Exits: 1
Investors Number: 1
Total Funding: 100000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-03-03
Last Funding Type: Private Equity

Visit Website
Register and Claim Ownership